Aducanumab Approved by FDA to Treat Alzheimer’s
The first drug since 2003 to treat Alzheimer’s patients was just approved by the US Food and Drug Administration (FDA). It was introduced under the trademark Aduhelm™. The drug, Aducanumab, is a therapeutic drug that clinically demonstrates a potential to…